Zydus Lifesciences consolidated net profit declines 26.47% in the September 2026 quarter

Sales rise 28.43% to Rs 7754.40 crore

Net profit of Zydus Lifesciences declined 26.47% to Rs 925.50 crore in the quarter ended September 2026 as against Rs 1258.60 crore during the previous quarter ended September 2025. Sales rose 28.43% to Rs 7754.40 crore in the quarter ended September 2026 as against Rs 6037.90 crore during the previous quarter ended September 2025.

Particulars	Quarter Ended
	Sep. 2026	Sep. 2025	% Var.
Sales	7754.40	6037.90	28
OPM %	24.43	33.39	-
PBDT	1864.90	2023.50	-8
PBT	1260.40	1721.60	-27
NP	925.50	1258.60	-26

Powered by Capital Market - Live News